A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary

See also
Status	Clinical Trial	Phase
Completed	`NCT00519506` - A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli	Phase 2
Not yet recruiting	`NCT04110275` - Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA)	Phase 2
Completed	`NCT05318092` - Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism	N/A
Not yet recruiting	`NCT06189313` - CLEANer Aspiration for Pulmonary Embolism	N/A
Not yet recruiting	`NCT05792397` - TwiFlow Thrombectomy Catheter sYstem for Acute Pulmonary Embolism (Twi-TYPE Study)	N/A
Completed	`NCT01604538` - Italian Pulmonary Embolism Registry - IPER	N/A
Completed	`NCT03631810` - Contemporary Clinical Management Of Acute Pulmonary Embolism
Recruiting	`NCT03504007` - Registry of Patients Prescribed Anticoagulation
Completed	`NCT01513759` - Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy	Phase 3
Completed	`NCT04037423` - European Database on Catheter-directed Treatment of Pulmonary Embolism.
Not yet recruiting	`NCT05469724` - Clinical Pulmonary Embolism
Completed	`NCT01014156` - Epoprostenol in Pulmonary Embolism	Phase 4
Recruiting	`NCT06038630` - 129Xe MRI Cardiopulmonary	Phase 2
Recruiting	`NCT06192199` - The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism
Recruiting	`NCT04757129` - Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism
Completed	`NCT03966079` - Thrombolysis Endovascular Treatment of Pulmonary Embolism	Phase 3
Recruiting	`NCT03916302` - Pulmonary Embolism WArsaw REgistry
Recruiting	`NCT06062329` - SYMPHONY-PE Study for Treatment of Pulmonary Embolism	N/A
Not yet recruiting	`NCT04480892` - Fibrinolytic Deficit in Patients With Acute PE
Enrolling by invitation	`NCT04047784` - Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients	N/A

NCT number	NCT03108833
Study type	Interventional
Source	Tasly Biopharmaceuticals Co., Ltd.
Contact
Status	Completed
Phase	Phase 2
Start date	June 6, 2017
Completion date	December 19, 2019

A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism — ERUPTE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms